We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Model Systems Assist Lung Disease Studies

By LabMedica International staff writers
Posted on 25 May 2017
Print article
Image: Brightfield images of day 50 LBO-derived Matrigel colonies from RUES2 cells (Photo courtesy of the Snoeck Laboratory at Columbia University Medical Center).
Image: Brightfield images of day 50 LBO-derived Matrigel colonies from RUES2 cells (Photo courtesy of the Snoeck Laboratory at Columbia University Medical Center).
Lung organoids generated from human pluripotent stem cells were shown to recapitulate lung development and were posited as potentially useful tools to model lung disease.

Investigators at Columbia University Medical Center generated lung bud organoids (LBOs) from human pluripotent stem cells (hPSCs). These organoid structures were grown in a Matrigel three-dimensional (3D) culture system and developed into branching airway and early alveolar structures that contained mesoderm and pulmonary endoderm tissues.

The investigators reported in the April 24, 2017, online edition of the journal Nature Cell Biology that they had used LBOs as model systems to study disease situations such as infection by respiratory syncytial virus (RSV) and mutation in the gene encoding HPS1 (Hermansky-Pudlak syndrome 1 protein), which causes an early-onset form of intractable pulmonary fibrosis.

Infection in vitro with RSV, which causes small airway obstruction and bronchiolitis in infants, led to swelling, detachment, and shedding of infected cells into the organoid lumens, similar to what has been observed in human lungs. Introduction of mutation in HPS1 led to accumulation of extracellular matrix and mesenchymal cells, suggesting the potential use of this model to recapitulate fibrotic lung disease in vitro.

"Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases," said senior author Dr. Hans-Willem Snoeck, professor of microbiology and immunology at Columbia University Medical Center. "But we have been tested by our limited ability to create organoids that can replicate key features of human disease. Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases."

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.